| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R Kaiser, P B Tremblay, J Schmider, M Henneken, M Dettling, B Müller-Oerlinghausen, R Uebelhack, I Roots, J Brockmölle. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Molecular psychiatry. vol 6. issue 2. 2001-06-28. PMID:11317220. |
the stin2.9 allele represented a risk factor for the residual subtype of schizophrenia (or: 6.4, ci: 2.5--16.2, p < 0.001). |
2001-06-28 |
2023-08-12 |
human |
| C A Schaefer, A S Brown, R J Wyatt, J Kline, M D Begg, M A Bresnahan, E S Susse. Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885630. |
high (> or = 30.0), compared with average (20.0-26.9), maternal prepregnant bmi (kg/m2) was significantly associated with schizophrenia and spectrum disorders in the adult offspring (relative risk [rr] = 2.9; 95% confidence interval [ci] 1.3-6.6), independently of maternal age, parity, race, education, or cigarette smoking during pregnancy. |
2000-11-03 |
2023-08-12 |
Not clear |
| C A Schaefer, A S Brown, R J Wyatt, J Kline, M D Begg, M A Bresnahan, E S Susse. Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885630. |
low (< or = 19.9) maternal bmi was not associated with schizophrenia and spectrum disorders (rr = 1.2; 95% ci 0.64-2.2). |
2000-11-03 |
2023-08-12 |
Not clear |
| J Wei, G P Hemming. A study of linkage disequilibrium between polymorphic loci for monamine oxidases A and B in schizophrenia. Psychiatric genetics. vol 9. issue 4. 2000-03-21. PMID:10697823. |
however, a significant excess of the (ac)18/(tg)23 haplotype with a relative risk of 4.05 (95%; ci 1.15-14.26) was observed in patients with schizophrenia (fisher's p = 0.011). |
2000-03-21 |
2023-08-12 |
human |
| H Verdoux, F Liraud, B Gonzales, O Fournet, P Pauillac, F Assens, F Abalan, J P Beaussier, C Gaussares, B Etchegaray, M Bourgeoi. [Prognosis of short-term outcome in the first admission for psychosis]. L'Encephale. vol 25. issue 3. 1999-12-29. PMID:10434146. |
persistence of psychotic symptoms (whatever their intensity) was associated with a diagnosis of schizophrenia broadly defined (or = 23.9, 95% ci 2.8-201.7, p = 0.003), with poor adjustment in the preceding year as measured by the global assessment of functioning (gaf) scale (or = 0.93, 95% ci 0.87-0.99, p = 0.04), and, at trend level, with older age at admission (or = 1.1, 95% ci 0.99-1.21, p = 0.07). |
1999-12-29 |
2023-08-12 |
human |
| H Verdoux, F Liraud, B Gonzales, O Fournet, P Pauillac, F Assens, F Abalan, J P Beaussier, C Gaussares, B Etchegaray, M Bourgeoi. [Prognosis of short-term outcome in the first admission for psychosis]. L'Encephale. vol 25. issue 3. 1999-12-29. PMID:10434146. |
prescription of antipsychotic drugs at discharge was independently predicted by low educational level (or = 5.5, 95% ci 1.2-25.4, p = 0.03), low gaf score (or = 0.94, 95% ci 0.90-0.99, p = 0.05), and, at trend level, by a diagnosis of schizophrenia broadly defined (or = 4.1, 95% ci 0.80-23.4, p = 0.09). |
1999-12-29 |
2023-08-12 |
human |
| O Mors, P B Mortensen, H Ewal. A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophrenia research. vol 40. issue 1. 1999-11-30. PMID:10541009. |
individuals with schizophrenia had a reduced risk for being admitted with rheumatoid arthritis [odds ratio 0.44 (ci 0.24-0.81)] in the case-control study. |
1999-11-30 |
2023-08-12 |
Not clear |
| R Segman, T Neeman, U Heresco-Levy, B Finkel, L Karagichev, M Schlafman, A Dorevitch, A Yakir, A Lerner, A Shelevoy, B Lere. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Molecular psychiatry. vol 4. issue 3. 1999-09-13. PMID:10395214. |
comparing the schizophrenia patients with and without td, genotypes containing the gly allele (drd3ser-gly and drd3gly-gly genotypes combined) were significantly associated with dyskinesia (or = 2.62, 95% ci 1.18-5.59, p = 0.02). |
1999-09-13 |
2023-08-12 |
Not clear |
| C Bergey, H Verdoux, F Assens, F Abalan, F Liraud, B Gonzales, J P Beaussier, C Gaussares, B Etchegaray, M Bourgeois, R Salamo. [Evaluation of the incidence of hospitalization of patients with psychotic disorders]. L'Encephale. vol 25. issue 1. 1999-06-17. PMID:10205731. |
the incidence rate of dsm iv schizophrenia was lower than that of psychotic mood disorders, and was equal to 0.13 per 1,000 (95% ci; 0.08-0.18). |
1999-06-17 |
2023-08-12 |
Not clear |
| P Räsänen, J Tiihonen, M Isohanni, P Rantakallio, J Lehtonen, J Morin. Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort. Schizophrenia bulletin. vol 24. issue 3. 1999-02-22. PMID:9718635. |
men who abused alcohol and were diagnosed with schizophrenia were 25.2 (95% confidence interval (ci) 6.1-97.5) times more likely to commit violent crimes than mentally healthy men. |
1999-02-22 |
2023-08-12 |
human |
| P Räsänen, J Tiihonen, M Isohanni, P Rantakallio, J Lehtonen, J Morin. Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort. Schizophrenia bulletin. vol 24. issue 3. 1999-02-22. PMID:9718635. |
the risk for nonalcoholic patients with schizophrenia was 3.6 (95% ci 0.9-12.3) and for other psychoses, 7.7 (95% ci 2.2-23.9). |
1999-02-22 |
2023-08-12 |
human |
| P Räsänen, J Tiihonen, M Isohanni, P Rantakallio, J Lehtonen, J Morin. Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort. Schizophrenia bulletin. vol 24. issue 3. 1999-02-22. PMID:9718635. |
none of the patients with schizophrenia who did not abuse alcohol were recidivists (> 2 offenses), but the risk for committing more crimes among alcoholic subjects with schizophrenia was 9.5-fold (95% ci 2.7-30.0). |
1999-02-22 |
2023-08-12 |
human |
| G Stöber, S Jatzke, A Heils, G Jungkunz, E Fuchs, M Knapp, P Riederer, K P Lesc. Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene. European archives of psychiatry and clinical neuroscience. vol 248. issue 2. 1998-10-22. PMID:9684917. |
the odds ratio for subjects with schizophrenia who were homozygous for the short allele was 1.04 (95% ci 0.59-1.84). |
1998-10-22 |
2023-08-12 |
human |
| T Mäkikyrö, J T Karvonen, H Hakko, P Nieminen, M Joukamaa, M Isohanni, P Jones, M R Järveli. Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia: a 28 year follow-up of the 1966 northern Finland general population birth cohort. Public health. vol 112. issue 4. 1998-09-25. PMID:9724944. |
epilepsy was strongly associated with schizophrenia (or = 11.1, 95% ci = 4.0-31.6). |
1998-09-25 |
2023-08-12 |
Not clear |
| T Mäkikyrö, J T Karvonen, H Hakko, P Nieminen, M Joukamaa, M Isohanni, P Jones, M R Järveli. Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia: a 28 year follow-up of the 1966 northern Finland general population birth cohort. Public health. vol 112. issue 4. 1998-09-25. PMID:9724944. |
nervous and sensory organ diseases in general (or = 2.5, 95% ci = 1.1-5.8) and inflammatory diseases of the bowel (or = 12.8, 95% ci = 3.8-42.7) were also overrepresented in schizophrenia when compared with people without a psychiatric disorder. |
1998-09-25 |
2023-08-12 |
Not clear |
| J R Copeland, M E Dewey, A Scott, C Gilmore, B A Larkin, N Cleave, C F McCracken, P E McKibbi. Schizophrenia and delusional disorder in older age: community prevalence, incidence, comorbidity, and outcome. Schizophrenia bulletin. vol 24. issue 1. 1998-04-28. PMID:9502553. |
the prevalence of dsm-iii-r schizophrenia was 0.12 percent (95% confidence interval [ci] 0.04-0.25) and delusional disorder 0.04 percent (95% ci 0.00-0.14). |
1998-04-28 |
2023-08-12 |
Not clear |
| J R Copeland, M E Dewey, A Scott, C Gilmore, B A Larkin, N Cleave, C F McCracken, P E McKibbi. Schizophrenia and delusional disorder in older age: community prevalence, incidence, comorbidity, and outcome. Schizophrenia bulletin. vol 24. issue 1. 1998-04-28. PMID:9502553. |
the minimum incidence of schizophrenia for new cases was 3.0 (95% ci 0.00 to 110.70); for new and relapsed cases, 45.0 (95% ci 3.54-186.20); and for delusional disorder, 15.6 (95% ci 0.02-135.10) per 100,000 per year. |
1998-04-28 |
2023-08-12 |
Not clear |
| P Räsänen, J Tiihonen, M Isohanni, J Moring, M Koirane. Juvenile mortality, mental disturbances and criminality: a prospective study of the Northern Finland 1966 birth cohort. Acta psychiatrica Scandinavica. vol 97. issue 1. 1998-04-28. PMID:9504696. |
there was a significantly higher mortality risk in men with schizophrenia (or, 9.31; 95% ci, 3.14-25.53), other psychoses (or, 10.28; 95% ci, 2.40-37.02), personality disorders (or, 4.28; 95% ci, 1.04-14.67) and combined personality disorders and criminality (or, 3.27, 95% ci, 0.99-9.59). |
1998-04-28 |
2023-08-12 |
Not clear |
| I Hovatta, J D Terwilliger, D Lichtermann, T Mäkikyrö, J Suvisaari, L Peltonen, J Lönnqvis. Schizophrenia in the genetic isolate of Finland. American journal of medical genetics. vol 74. issue 4. 1997-11-06. PMID:9259368. |
the risk of schizophrenia to siblings in the internal isolate was 6.4% (95% confidence interval 0.052, 0.078), 9.1% (95% ci 0.062, 0.130), and 6.8% (95% ci 0.028, 0.135) given 1, 2, or 3 affected siblings, and for all finland 4.2% (95% ci 0.036, 0.043), 6.4% (95% ci 0.058, 0.071), and 8.7% (95% ci 0.068, 0.107) given 1, 2, or 3, affected siblings, respectively. |
1997-11-06 |
2023-08-12 |
Not clear |
| E Hadasová, G Franke, M Zschiesche, E Cesková, O Zelenková, W Siegmun. Debrisoquine 4-hydroxylation and sulphamethazine N-acetylation in patients with schizophrenia and major depression. British journal of clinical pharmacology. vol 41. issue 5. 1996-10-17. PMID:8735687. |
the prevalences of pm amongst patients with chronic schizophrenia and major depression were 10.9% (95% ci 4.5-21.3%) and 5.9% (95% ci 1.24-16.3%), respectively (chi 2 schizophrenics vs control = 0.315, ns; chi 2 depressive patients vs control = 0.450, ns). |
1996-10-17 |
2023-08-12 |
human |